Negative Selection in Cell Therapy: Unlocking Better Treatment Potential 

Akadeum explores the advantages of negative selection in the immunotherapy field for cell isolation.  In this webinar, a panel of leading cell therapy experts provides exclusive insights into the power of negative selection, a rapidly advancing field, while navigating the benefits of using untouched cells in cell therapy.  Negative selection is now revolutionizing cell-based therapy treatments, elevating therapeutic strategies, and making a real impact on patient outcomes.  Learn how you can harness the latest innovations in cell therapy with Akadeum. 

Webinar Panelists: 

	Dawn Maier Cell & Gene Therapy - CMC Advisor Dawn Maier Consulting
	Hannah W. Song Biologist, Product Development NIH Center for Cellular Engineering
	Bill Lloyd Sr. Director of R&D Akadeum Life Sciences